| Name | Brockie Pharmatech |
|---|---|
| Organization Name | Brockie Healthcare Incorporated |
| Location | 209 N Beaver St, York, Pennsylvania 17405 |
| Type | DME Supplier - Parenteral & Enteral Nutrition |
| Phone | (717) 854-9028 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function.
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.
OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
› Verified 3 days ago
| NPI Number | 1730242660 |
| Organization Name | BROCKIE HEALTHCARE INCORPORATED |
| Doing Business As | BROCKIE MEDICAL SUPPLY |
| Type | DME Supplier - Parenteral & Enteral Nutrition |
| Address | 209 N Beaver St, York, PA 17403 |
| Phone Number | 717-843-1541 |
News Archive
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function.
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.
OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
› Verified 3 days ago
| NPI Number | 1740339688 |
| Organization Name | BROCKIE HEALTHCARE INCORPORATED |
| Doing Business As | BROCKIE PHARNATECH |
| Type | Long Term Care Pharmacy |
| Address | 209 N Beaver St, York, PA 17401 |
| Phone Number | 717-848-3445 |
News Archive
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function.
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.
OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
› Verified 3 days ago
| NPI Number | 1932359593 |
| Organization Name | BROCKIE HEALTHCARE,INC. |
| Type | Long Term Care Pharmacy |
| Address | 209 N Beaver Street, York, PA 17401 |
| Phone Number | 717-854-9028 |
News Archive
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function.
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.
OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
› Verified 3 days ago
News Archive
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function.
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.
OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
› Verified 3 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2350 Freedom Way, York, Pennsylvania 17402 Phone: (717) 741-3222 | |
Cvs Pharmacy #01657 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2080 S Queen St, York, Pennsylvania 17403 Phone: (717) 845-1633 | |
Cvs Pharmacy #07677 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 165s Richland Ave, York, Pennsylvania 17404 Phone: (717) 843-4730 | |
Cvs Pharmacy #04215 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 820 Edgewood Rd, York, Pennsylvania 17402 Phone: (717) 757-6252 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2350 Freedom Way, York, Pennsylvania 17402 Phone: (717) 741-6682 |